A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...

The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.

Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing.

Eli Lilly and Company (LLY) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved a label ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

UCLA's study identifies distinct Alzheimer's disease trajectories, emphasizing the role of shared risk factors in early detection and targeted interventions.

A single, freely available, noninvasive brain scan done in just a few minutes during midlife can predict what chronic ...

UCLA Health researchers mapped four distinct pathways leading to Alzheimer’s disease using electronic health records.   The ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

Dr. Marty Levine explains more about the disease and the support that's available for patients. Sponsored by Optum Care ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...